Jilin Province Huinan Changlong Bio-pharmacy Company Limited (SEHK: 8049)
Health Care · Pharmaceuticals · HK
HK$2.42
+4.09% today · +10.0% 1Y
Jilin Province Huinan Changlong Bio-pharmacy Company Limited (SEHK: 8049) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $172.77M and employs 1,107 people.
Over the last twelve months the share price has gained 10.0%, trading between 1.82 and 3.00.
Tweenvest scores Jilin Province Huinan Changlong Bio-pharmacy Company Limited across four factors: quality 88/100, value 50/100, growth 56/100, dividend 100/100. Its strongest factor is dividend.
8049 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $172.77M
- Revenue (TTM)
- $132.21M
- P/E
- 5.37
- EPS
- 0.39
- Dividend yield
- 11.28%
- Beta (5Y)
- 0.29
- 52-week high
- HK$3.00
- 52-week low
- HK$1.82
- Avg volume (3M)
- —
- Shares outstanding
- 560.25M
- Employees
- 1,107
- Next earnings
- —
About Jilin Province Huinan Changlong Bio-pharmacy Company Limited
Jilin Province Huinan Changlong Bio-pharmacy Company Limited focuses on the manufacturing and sale of traditional Chinese medicines and various pharmaceutical products within the People's Republic of China. The company's extensive product portfolio includes a wide range of dosage forms such as tablets, capsules, and pills, as well as specialized items like Chinese medicine pretreatment and extraction products. They also provide various injectable solutions, including powders for injection, lyophilized powders for injection, and small volume liquid injections, along with active pharmaceutical ingredients (APIs) and granules. These products are primarily sold under the "Changlong" and "Qing Tong" brand names. Established in 1989, and headquartered in Kowloon, Hong Kong, the company was previously known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited.
- ISIN
- CNE100000130
- Founded
- 1989
- Listed since
- May 24, 2001
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Oramed Pharmaceuticals Inc.NasdaqCM: ORMP | $180.12M | $4.25 | -1.85% |
| Journey Medical CorporationNasdaqCM: DERM | $178.10M | $5.92 | -6.26% |
| Highnoon Laboratories LimitedKASE: HINOON | $177.77M | PKRs929.10 | +0.01% |
| IT-Chem CO.,LtdKOSDAQ: A309710 | $173.78M | ₩— | — |
| Kahira Pharmaceuticals & Chemical Industries CompanyCASE: CPCI | $171.93M | EGP602.90 | +1.21% |
| JBM (Healthcare) LimitedSEHK: 2161 | $169.76M | HK$1.63 | +1.88% |
| Binh Dinh Pharmaceutical and Medical Equipment Joint Stock CompanyHOSE: DBD | $169.19M | ₫46,350.00 | -0.86% |
| Mecure Industries PLCNGSE: MECURE | $169.05M | ₦56.20 | -9.94% |
Figures last refreshed Oct 11, 2026.